You are here
Board of Directors
Linda L Carpenter
Providence, Rhode Island
San Francisco, California
Ian A Cook
Los Angeles, California
Director, Los Angeles TMS Institute, Inc.
Professor Emeritus of Psychiatry and Bioengineering, UCLA
Founding Director of UCLA TMS Service (2009)
Richard J. Pitch
Medford, New York
kevin M kinback
Ladera Ranch, California
Dr. Kinback has been providing TMS as an in-network provider longer than any other doctor in Orange County. He is a founding member of the TMS Society, currently on the Board of Directors, and Co-Chair of the Insurance Committee. He has also served on Executive Research, Standards, Newsletter and Education committees. Graduating from Loma Linda University Medical School in 1992, Dr. Kinback did psychiatry training at Loma Linda, was Chief Resident, and remains on the faculty as Assistant Clinical Professor of Psychiatry. He also has faculty appoints to Dubuque University and Johns Hopkins. His private practice in Orange County began in 1995. With a keen interest in cutting-edge medicine, Advanced TMS was founded in 2009. Specializing in TMS therapy for treatment-resistant depression, and OCD, Dr. Kinback has treated hundreds with TMS therapy. A brand new, upscale office opened in late 2018 in Ladera Ranch as the new headquarters, and new providers are being added to the group at this time.
F. Andrew Kozel
John P O'Reardon
Voorhees, New Jersey
Dr. O’Reardon has been in practice as a psychiatrist for 30 years. He completed his residency training at Penn and Fellowships in Psychopharmacology & Cognitive Therapy (including training at the Beck Institute). In his clinical work as a faculty member at Penn he focused on treatment-resistant mood disorders and neuromodulation. This is the development of brain devices to stimulate the brain and treat mood disorders. These devices, which are increasing all the time, include transcranial magnetic stimulation (TMS), deep brain stimulation (DBS), vagus nerve stimulation (VNS), EEG-synchronized TMS (sTMS), deep TMS (dTMS) and transcranial direct current stimulation (tDCS).
Dr. O’Reardon was an active educator at Penn and over the years helped train more than a hundred psychiatry residents. He taught courses on neuromodulation, mood disorders and the History of Psychiatry. He has been a recipient of numerous teaching awards including the Earl Bond Award for excellence in teaching. He has been a frequent presenter at the annual meeting of the American Psychiatric Association (APA). Most recently he has presented a symposium on historical figures and mood disorders called Art, Politics and Creativity: Resilience in the Face of Great Odds – including Abraham Lincoln, Vincent Van Gogh, Winston Churchill and Sylvia Plath.
Dr. O’Reardon has been an active and productive researcher during his career. He has authored over a hundred publications in his career encompassing new brain devices (TMS, sTMS, VNS, DBS and tDCS), major depression, bipolar disorder, ECT and the night eating syndrome. He has been a lead investigator in many cutting edge clinical trials of new treatments for patients. He is first author on the primary trial that led to FDA approval for TMS as new exciting treatment for major depression. His current research work is with another exciting emerging treatment modality for major depression, namely tDCS.
Karl I. Lanocha
r. David Feifel earned a Bachelor of Science, Master’s Degree and a Ph.D. (Neurobiology) from the University of Toronto, Canada. He also earned a Medical Degree from University of Toronto’s Medical School, one of the top ranked in the world. After completing an internship in Internal Medicine at the Toronto General Hospital, Dr. Feifel completed a Psychiatry residency at the University of California, San Diego, serving as outpatient Chief Resident in his final year. Upon finishing his residency, he was recruited to join UCSD’s School of Medicine as a faculty member and rose to rank of full Professor in the Department of Psychiatry and in the Neuroscience graduate program.
At UCSD Dr. Feifel was Director of the Neuropsychiatry and Behavioral Medicine Program, was the founder and Director of the UCSD Adult ADHD program, and created the Department of Psychiatry’s Center for Advanced Treatment where he introduced several novel treatments such as Transcranial Magnetic Stimulation (TMS) and Ketamine. He was one of the first providers in the country to utilize these treatments. At UCSD, Dr. Feifel also regularly taught medical students, residents and postdoctoral fellows and headed a translational research program focused on developing new treatments for psychiatric disorders.
In 2017, Dr. Feifel decided to resign his full-time tenured appointment at UCSD and established Kadima Neuropsychiatry Institute and the Kadima Brain Initiative in order to more effectively pursue his passion for developing and utilizing cutting edge, non-invasive treatments for neuropsychiatric disorders. Dr. Feifel maintains an active appointment as Professor Emeritus of Psychiatry, within UCSD’s School of Medicine
Among his distinctions, Dr. Feifel is an elected member of the American College of Neuropharmacology, he has been elected by his peers for inclusion in ‘Best Doctors in America’, and he is cited in the Castle Connelly list of “Top Doctors:” a distinction bestowed on only 10 psychiatrists in San Diego.
In addition to being a Diplomate of the American Board of Psychiatry and Neurology in General Psychiatry, he is also certified in the sub-specialties Psychosomatic Medicine, and holds certification from the United Council of Neurological subspecialties in Behavioral Neurology and Neuropsychiatry, a certification only held by only three physicians in San Diego.
Dr. Feifel continues to conduct research into developing new treatment approaches to mental illness at Kadima Neuropsychiatry Institute and he heads an NIH funded research laboratory at the VA Medical Center in San Diego. He has authored or co-authored over 100 original scientific research papers and multiple research abstracts and book chapters on the topic of psychiatric illness and their treatments. Dr. Feifel lectures internationally on novel treatments for brain disorders. His research has received funding grants from the National Association for Research in Schizophrenia and Depression (NARSAD), the Scottish Rite Organization, the Stanley Medical Research Institute, Kavli Institute for Brain and Mind and the National Institutes of Health (NIH).
In private practice in Psychiatry since January 2000, Dr. Kimberly Cress brings her extensive experience for difficult to treat mental illnesses to Greenbrook TMS located in Sugar Land, TX and serving the Greater Houston area. A graduate from the University of Texas Health Science Center, San Antonio Medical School, Dr. Cress’ vast experience includes treating patients with treatment refractory depression, anxiety disorders and bipolar disorders at the Mood Disorder Center at Baylor College of Medicine. She was also involved with a variety of clinical trials and a co-author in several journal articles.
After finding patients were still struggling with depression and anxiety despite numerous medication trials and/or therapies, Dr. Cress chose to incorporate TMS therapy as a treatment option to help patients regain the quality of life they deserved – without the unwanted side effects. Dr. Cress has treated patients with TMS therapy since April 2010 and has administered over 15,000 treatments. She has completed Harvard Medical School’s Intensive Course in Transcranial Magnetic Stimulation and Transcranial Direct Current Stimulation, along with completing courses at Duke University in Transcranial Magnetic Stimulation. Dr Cress has presented her results utilizing TMS both at the Clinical TMS Society as well as at the American Psychiatric Association. In addition, she teaches at the Clinical TMS Society's Pulses course about best practices for providing TMS.
Dr. Cress’ goal is to tailor each person’s care to live life without a mental illness. “Treating depression is an art as well as a science. It is important to listen to each person and their history to determine the most effective depression treatment plan. Why should anyone settle for just feeling ‘OK’?”
Poughkeepsie, New York
Randy Ian Pardell, MD, DFAPA established TMS Center of the Hudson Valley and Riverview Psychiatric Medicine, PC with the goal of providing innovative, compassionate and scientifically based psychiatric care for residents of the Hudson Valley, NY.
Dr. Pardell emphasizes, “We address both the physiological and psychological aspects of each patient to create the optimal individualized treatment plan including medication management, genetic testing, psychotherapy, nutritional and bioidentical hormone supplementation and Transcranial Magnetic Stimulation (TMS). Dr. Pardell, a board-certified psychiatrist and Distinguished Fellow of the American Psychiatric Association, graduated from the University of Pennsylvania, Magna Cum Laude, Phi Beta Kappa, and the New York University School of Medicine with honors. He completed psychiatric training at St. Luke’s-Roosevelt Hospital Center where he served as chief resident and was a post-doctoral fellow at Columbia University School of Medicine. He completed, with distinction, The Master in Pharmacology Program sponsored by Neuroscience Educational Institute. Dr. Pardell completed a Mini-Fellowship in Transcranial Magnetic Stimulation from Harvard Medical School at the Berenson-Allen Brain Stimulation Center at Beth Israel-Deaconess Hospital Center in Boston and Visiting Fellowship in Transcranial Magnetic Stimulation at Duke University School of Medicine. Dr. Pardell is an Assistant Professor of Clinical Medicine at Eastern Virginia Medical School and lectures to medical students and residents to further their education in psychiatry.
As a highly regarded lecturer, Dr. Pardell has educated fellow physicians and mental health clinicians on the latest pharmacologic and innovative treatments of psychiatric disorders. He was recognized by Castle Connolly as a Top Doctor in the Hudson Valley in the Hudson Valley Magazine and Top Doctor in Castle-Connolly/ US and News and World Report. Dr. Pardell was acknowleged by his patients with the Patient Choice Award and Compassionate Doctor Recognition. Dr. Pardell is an active member of the Clinical TMS Society and is serving on the Board of Directors, Excecutive Committee as Officer at Large. Dr. Pardell also serves on the Outreach and Education Committees and is a lecturer for the Society’s Pulses Course educating fellow clinicians in the science and practice of Transcranial Magnetic Stimulation.
Dr. Cochran received her undergraduate degree from Centre College in Danville, Kentucky, and completed her medical training at the University of Louisville School of Medicine. She received postgraduate medical education at Vanderbilt University Medical Center in Nashville, TN, where she completed a residency in Psychiatry. During this residency she was Chief Resident. Additionally, she completed the Management Program for Physicians and Senior Healthcare Administrators at Vanderbilt University's Owen School of Management. A diplomat of the American Board of Psychiatry and Neurology, Dr. Cochran is a member of the Tennessee Psychiatric Association, Tennessee Medical Association, Nashville Academy of Medicine, the Clinical TMS Society and Tennessee Women in Medicine. Since her residency years, she has been a member of the American Psychiatric Association, and in early 2011, she was inducted as a Fellow in this organization. Dr. Cochran has been on the Clinical Faculty in the Department of Psychiatry at Vanderbilt University Medical Center since 1996 and has lectured to undergraduate, graduate, and postgraduate students as well as private practitioners. For over 20 years, she has been active on numerous advisory boards professionally and personally. Before retiring from inpatient psychiatric care and establishing her outpatient private practice, she was the medical director for many psychiatric units and programs in the Middle Tennessee area. Dr Cochran currently works in a private practice in Nashville. She has experience treating a variety of psychiatric conditions, using therapy, counseling, medicines, neuro-modulation, and integrative care options. Dr. Cochran and her staff have trained extensively in the use of repetitive Transcranial Magnetic Stimulation (rTMS) including training at Harvard (Berenson Allen), Duke and other training. Dr Cochran has spoken nationally on the use of rTMS in a clinical setting in both industry and continuing education venues. Dr. Cochran has been a integral part of the Clinical TMS Society.
Rebecca M. Allen
Dr. Allen graduated with a B.A. in Psychology with honors from Stanford University. She attended Oregon Health and Science University for medical school where she also earned a Masters of Public Health in biostatistics and epidemiology. She completed psychiatry residency at the Harvard Longwood Psychiatry Residency Training Program, a joint program between Brigham and Women’s Hospital, Beth Israel Deaconess Medical Center, and Massachusetts Mental Health Center. She served as Chief Resident of the psychiatry consult service at Beth Israel Deaconess Medical Center. She then went on to complete a 2-year fellowship in Neuropsychiatry at Brigham and Women’s Hospital.
Dr. Allen has participated in research on sleep and memory consolidation, quality of life in multiple sclerosis, and other projects. She has authored several papers. Her main clinical interest is neuropsychiatry: she is trained in the neurobiological bases and treatment of cognitive, behavioral, and neuropsychiatric manifestations of neurodegenerative diseases (dementia), multiple sclerosis, epilepsy, stroke, brain tumors, developmental disorders, traumatic brain injury, and other disorders. Other clinical interests include electroconvulsive therapy, transcranial magnetic stimulation, and the interaction between sleep and psychiatric disorders.
BOGOTA, Distrito Capital de Bogotá
Suzanne E. Kerns
Charleston, South Carolina
Dr. Kerns completed her undergraduate studies at the University of North Carolina in Chapel Hill. She attended medical school at the University of Sydney, Australia, followed by psychiatry residency at Duke University. Dr. Kerns subsequently completed a year long Fellowship in Brain Stimulation at Medical University of South Carolina under the guidance of Mark S. George MD, a founding father of transcranial magnetic stimulation (TMS). After several years working exclusively in brain stimulation at Seattle Neuropsychiatric Treatment Center with a faculty appointment at the University of Washington, she has returned to South Carolina and is an Assistant Professor of Psychiatry at the Medical University of South Carolina.
Dr. Kerns proudly serves on the Board of Directors for the Clinical TMS Society. She is also a member of the American Psychiatric Association, South Carolina State Psychiatric Association, International Society for ECT and Neurostimulation and Society of Biological Psychiatry.
Garden City, New York
As an Associate Professor of Psychiatry at Harvard Medical School, Dr. Bush gained internationally-recognized expertise in the neuropathophysiology and psychopharmacological treatment of ADHD, depression and other mood and anxiety disorders; as well as in the brain processes underlying attention, cognition, emotion and anxiety. Following his graduation from SUNY at Buffalo School of Medicine & Biomedical Sciences in 1990 and his Psychiatric Chief Residency at Stony Brook University Hospital in 1994, Dr. Bush completed two clinical research fellowships. The first was a Harvard/MGH clinical research training program in biological and social psychiatry. In recognition of his second two-year Harvard-M.I.T. clinical investigator fellowship, he was granted an additional Master’s Degree in Medical Science from Harvard Medical School.
Dr. Bush has nearly three decades of clinical experience treating patients of all ages in a variety of settings including outpatient, inpatient, consult-liaison, crisis units and both psychiatric and medical emergency rooms. Dr. Bush served on the Editorial Board of the journal, Biology of Mood & Anxiety Disorders and is a proud member of the Clinical TMS Society. As the Director of Neuroimaging at the Benson-Henry Institute for Mind-Body Medicine at MGH, he gained an appreciation for complementary forms of treatment such as meditation and relaxation response training. Dr. Bush has more than 50 publications in medical-scientific journals and books.
Dr. Bush is the Chief Medical Officer of MagnetiCareTMS of Long Island, which provides state-of-the-art NeuroStar transcranial magnetic stimulation (TMS) therapy for patients with depression in a comfortable, spa-like setting. Dr. Bush’s goal is to translate cutting-edge advances of TMS technology, functional and structural brain imaging, pharmacogenomics and neuropsychopharmacology research into compassionate, individualized treatments for patients in need.
I am the Medical Director of Washington Square Psychiatry & TMS, doing TMS for over 5 years. As an expert integrative psychiatrist, I assess every new TMS patient at Intake, which includes genetic and EEG baseline markers. I provide ongoing personalized psychiatric management throughout the course of TMS care. This has led to optimized TMS outcomes, with the majority of patients achieving full and durable recovery.
Mahmoud S Okasha
David R Greeley
Dr Todd Hutton is the founder and Medical Director of Southern California TMS Center and has been practicing TMS since 2009. He is a Board Certified psychiatrist and an Associate Clinical Professor of Psychiatry at the USC Keck School of Medicine. He did his residency in psychiatry at the LA County/USC Medical Center and served as Chief Resident his final year. He subsequently did a fellowship in TMS at Duke University. He serves on the Board of Directors and is President of the Clinical TMS Society.
Paul E. Croarkin
Immediate Past President